:max_bytes(133120)/d2j5s05om7evfr.cloudfront.net/pubmed-llm-images/40012185/b27a2b060a5463175d129b1aab3b0a6b_wm.png)
Boswellic Acids Reduce Systemic Inflammation in Patients with Moderate COVID-19 Through Modulation of NF-κB Pathway.
Summary: Scientists have found that a syrup made from Boswellic acids—active compounds found in frankincense—may help patients with moderate COVID-19. In a 14-day study, patients taking the "Inflawell" syrup showed a significant drop in dangerous inflammation markers compared to those taking a placebo. The study revealed that these natural acids work by calming the "NF-κB pathway," a cellular switch that controls immune reactions. This suggests that this ancient herbal remedy could serve as a modern tool to prevent the immune system from overreacting during a COVID-19 infection.
Tags
Disease
Neoplasms
Inflammation
Necrosis
COVID-19
NF-kappa B
Receptors, Tumor Necrosis Factor
Interleukin 1 Receptor Antagonist Protein
Chemotactic Factors
Receptors, Tumor Necrosis Factor, Type I
Chemokine CCL2
Monocyte Chemoattractant Proteins
Receptors, Tumor Necrosis Factor, Type II